glp 1 and dental issues Medscape | After all the headlines about “Ozempic mouth” — “Ozempic breath” and “Ozempic teeth” — emerging research points to possible Patients taking Ozempic or other

Semaglutide, tirzepatide, and other GLP-1-based therapies may help appropriate patients achieve meaningful weight loss, but long-term results depend on what happens next: follow-up, strength, protein, hydration, lab monitoring, dose review, and realistic planning

Cancellation requires emailing support, and multi-month refunds are generally not provided

Semaglutide is not contraindicated in Graves' disease, but it requires close physician coordination with your endocrinologist

Considerations regarding adverse effects and contraindications for different drug classes are provided to help guide treatment decision-making when considering pharmacotherapy for weight management in patients with obesity

The above dosages and indications are general guidelines and may vary based on individual patient needs and clinical judgment